Evidence map›Paper›PMID 41768543›Full record

ArticleArchives of clinical and medical case reports2024

Nisin ZP Combined with Limited Chemotherapy in Oropharyngeal Squamous Cell Carcinoma: A Case Report.

Qianlin Ye, Aimin He, Yeping Wu, Yvonne L Kapila

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of clinical and medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qianlin YeSection of Biosystems and Function, School of Dentistry, University of California Los Angeles, Los Angeles, CA, USA.
Aimin HeHandary, Rue Colonel Bourg 127, 1140 Brussels, Belgium.
Yeping WuHandary, Rue Colonel Bourg 127, 1140 Brussels, Belgium.
Yvonne L KapilaSection of Biosystems and Function, School of Dentistry, University of California Los Angeles, Los Angeles, CA, USA.

Funding

UCLA Dental Specialty PhD ProgramK12DE027830 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Yvonne L Kapila · 2018 to 2026
$1.5M
NIDCR NIH HHS K12 DE027830
6 · The paper itself

Abstract

Objective: This case report describes and discusses the therapeutic potential of nisin ZP as adjunctive therapy in patients with oral squamous cell carcinoma (OSCC). Case Report: A 43-year-old Asian male with OSCC initiated treatment with Paclitaxel and Cisplatin chemotherapy. Nisin ZP was administrated during and after the chemotherapy. Results: The patient experienced symptom relief and significant tumor regression following administration of nisin ZP. Conclusion: Nisin ZP shows promising potential as an adjunctive therapy for OSCC, offering symptom relief and contributing to tumor size reduction.

Indexed as

Adjunctive therapyNisin ZPOral squamous cell carcinoma

Identifiers

PMID41768543
PMCPMC12945336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.